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 Background: Aneurysmal subarachnoid hemorrhage (aSAH) is a destructive syndrome with a mortality rate of 50%. Recent 
studies have also suggested a high pervasiveness of hypothalamic-pituitary insufficiency in up to 45% of pa-
tients after aSAH. Prolactin has been associated with the pathogenesis of hypertensive irregularities that are 
linked to pregnancy.
 Material/Methods: We identified a group of 141 patients with spontaneous SAH due to a ruptured cerebral aneurysm; these pa-
tients were operated on at our institution’s Neurosurgery and Interventional Radiology Department between 
2011 and June 2015. All of the data were obtained retrospectively from medical records.
 Results: The hormonal abnormalities observed in the initial 24 h after ictus in subjects with subarachnoid SAH were 
caused by stressful stimulation aggravated by intracranial bleeding.
 Conclusions: The elevated prolactin levels that occur in patients with aSAH can be used in conjunction with other auxiliary 
factors that we believe may be beneficial to vasospasm.
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Background
Aneurysmal subarachnoid hemorrhage (aSAH) is a destructive 
syndrome with a mortality rate of 50%. In spite of all medical 
care efforts, 30% of survivors experience perpetual neurologi-
cal impairment [1]. A considerable factor influencing outcome 
following treatment of a fractured aneurysm is the neurolog-
ical condition of the accepted patients, which largely reflects 
the severity of the hemorrhage. Other risks include recurrent 
bleeding, initial and secondary vasospasm, and the complex-
ity of the therapeutic intervention [1,2].
Recent studies have also suggested that hypothalamic-pi-
tuitary insufficiency is very common following aSAH [3–5]. 
Hyperprolactinemia (HPRL) is physiological condition that oc-
curs after intercourse and stressful activity, and during lacta-
tion and pregnancy. The expected rate of HPRL is 0.4–3% in a 
healthy population. Prolactin has a crucial role in modulating 
the immune response [2].
Previous studies have linked dysfunction and subarachnoid 
hemorrhage (SAH). A number of studies have suggested that 
endocrine disorders are induced by compression of the hypo-
thalamus-pituitary complex by the aneurysm. Other reported 
causes are SAH due to perfusion changes, toxins from erupt-
ed blood, vasospasm-related ischemia, hydrocephalus, and 
high intracranial pressure. One additional cause is injury dur-
ing the surgical procedure [3,4,6,7].
A relationship between prolactin and the pathogenesis of preg-
nancy-related hypertensive disorders has been reported [8,9]. 
Reports on the hormone levels in these disorders show they are 
increased, within normal limits, or decreased [10,11]. There is 
scant evidence regarding the dominant blood flow and resis-
tance effects of prolactin in intact blood vessels, but reports 
have associated prolactin with vascular effects. Prolactin as an 
i.v. infusion has been reported to boost arterial pressure in de-
cerebrate rabbits [12] and to decrease renal blood flow, elevate 
body fluid level, and increase the pressor response to norepi-
nephrine in rats. The N-terminal 16-kDa particle of prolactin 
was proved to prevent coronary vessel relaxation of isolated 
perfused animal hearts. There are also reports of deterioration 
of endothelial vasodilatory function and insulin susceptibility 
in subjects with pituitary adenoma and hyperprolactinemia. 
Prolactin i.v. infusion primarily leads to a decline in blood flow 
and elevation in coronary vascular resistance, mesenteric, re-
nal, and iliac vascular beds. The structure behind these ef-
fects was proven to include beta 2-adrenergic receptor-me-
diated effects linked to the intracellular NO pathway [13,14].
Pituitary prolactin is a 200-amino acid peptide hormone 
synthesized in and secreted from the anterior pituitary [9]. 
Several lines of evidence suggest that prolactin is secreted 
in the periphery by lymphohematopoietic cells. A number 
of endogenous and exogenous factors modulate prolac-
tin secretion but, for the purposes of this review, estrogen 
and dopaminergic agonism are pivotal. Circulating prolac-
tin binds to the prolactin receptor and its various isoforms 
with specific downstream effects, as would be expected for 
a receptor that belongs to the growth hormone, erythropoi-
etin, and cytokine receptor superfamily. Signal transduction 
of the prolactin receptor leads to gene transcriptional reg-
ulation. Interestingly, prolactin and the immunosuppressive 
drug cyclosporine appear to be antagonistic through a re-
ceptor-based mechanism.
Material and Methods
We identified a cohort of 141 patients with spontaneous SAH 
due to a ruptured cerebral aneurysm; these patients were oper-
ated on in Baskent University Neurosurgery and Interventional 
Radiology Department between September 2011 and June 2015. 
This study was approved by Baskent University Institutional 
Review Board (Project no: KA 17/165) and supported by Baskent 
University Research Fund. All of the data were obtained retro-
spectively from medical records.
Cerebral angiography was conducted in all patients to deter-
mine localization of the aneurysm. All patients that had an 
SAH underwent brain computed tomography (CT) and results 
of the CT were noted.
According to the findings of cranial digital subtraction angi-
ography, the localization of the aneurysm, the aneurysm neck 
diameter, length, and the ratio of the dome and neck length 
were all recorded. Basal hormone levels of the patients were 
taken within 12 h of their admission.
Patients that used confounding drugs earlier, such as substi-
tuting hormonal therapy of all types, were excluded from this 
study. Patients using drugs that might affect pituitary func-
tion, such as glucocorticoids or dopamine, were additionally ex-
cluded. We measured fundamental hormone status along with 
free (f) T3, fT4, TSH, PRL, cortisol, FSH, LH, and macroprolactin.
We made a diagnosis of spontaneous SAH according to an-
amnesis, physical findings, and brain CT data. Then, dilatation 
was detected using four-vessel conventional x-ray angiogra-
phy (all carotids and all vertebrals) via femoral artery cathe-
terism. When the localization of the aneurysm was visualized, 
the image of the neck was recorded. The Fisher CT score cor-
responds to: (1) No blood detected; (2) A diffuse disposition 
or thin layer with all vertical layers of blood (interhemispheric 
fissure, insular cistern, ambient cistern) less than 1 mm thick; 
(3) Localized clots and/or vertical layers of blood 1 mm or more 
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in thickness; and (4) Diffuse or no subarachnoid blood, but in-
tracerebral or intraventricular blood [10].
Following hospital admissions, the patients were clinically as-
sessed and categorized in accordance with the World Federation 
of Neurosurgical Societies (WFNS) SAH grading scale, which is 
used exclusively in patients with SAH for clinical and predictive 
assessment. All of the patients were tracked until they were 
released from the hospital. Prior to release, the patients were 
re-evaluated using the prognostic WFNS scale [15].
We collected blood samples at 8 AM and 9 AM, 24 h upon ictus, 
centrifuged at 3000 rpm, for 10 min. We stored the serum at 
–20° C until we conducted the assays. We measured hormones 
using commercial kits: T4 by RIA (INEP, Zemun, Serbia); TSH by 
IRMA (INEP); PRL, LH, and FSH by IRMA (Cis BioInternational, 
France); and cortisol by RIA (Cis BioInternational).
Statistical analysis
Statistical analysis was performed using SPSS 20.0.
Normality of distributions of continuous variables was deter-
mined by Kolmogorov-Smirnov test. Descriptive statistics for 
continuous variables are expressed as mean ±SD or medi-
an (25th–75th) percentiles, where applicable. Numbers of cas-
es and percentages were used for categorical data. The mean 
differences between groups were compared by the t test, and 
Mann-Whitney U test was used for comparisons of non-nor-
mally distributed data.
Results
We identified 141 eligible patients, but 17 patients who were 
lost to follow-up were excluded. We included 124 patients in 
the analysis. There were 49 females and 75 males, with an 
average age of 56.33±11.17 years, and there were no statis-
tically significant differences between the average age of fe-
males (52.5±14.8 years) and males (51±3.3 years). Aneurysm 
location sites are listed in Table 1. Fifty-three subjects were 
categorized as grade I in the WFNS grading scale (asymptom-
atic or with minimal to discrete headache), 37 patients were 
classified as grade II (headache levels moderate to severe, stiff 
neck, and absence of focal neurological signs, excluding crani-
al nerves paralysis), and 19 patients were classified as grade 
III (sleepiness, mental confusion, and discreet focal neurolog-
ical deficits), 28 patients were classified as grade IV, and 4 pa-
tients were classified as grade V.
We assessed endocrine levels at 7.4±6.6 h after SAH. Prolactin 
levels were significantly correlated with Fischer grade on CT 
(Pearson correlation coefficient: 0.59, p<0.0001). The mean 
prolactin levels were 8.23±5.15 (15 patients) in Fischer grade I, 
12.93±12.60 (48 patients) in Fischer grade II, 36.08 ± 19.39 (50 
patients) in Fischer grade III, and 43.29±24.33 (28 patients) in 
Fischer grade IV. There were significant differences between 
prolactin levels with Fischer grades and WFNS grades of the 
patients (Pearson correlation coefficient 0.496, p<0.0001). 
The mean prolactin levels were lower for patients with lower 
Fischer grades (p<0.0001), and there were no differences be-
tween prolactin levels and sex (p=0.328). Radiologically, va-
sospasm was observed in patients with high prolactin levels 
in diagnostic cerebral angiography, and the aneurysm was 
closed within 24 h.
The TSH, T3, and T4 levels in men and women were compara-
ble. TSH levels were higher than normal in 5 patients (14.2%). 
T3 levels characterized by a mean value of 33.8±9 ng/dL, were 
found lower than normal in 5 patients (14.2%). The T4 levels 
were low in 2 patients (5.6%). Antithyroglobulin and antimi-
crosomal antibodies were not identified in any of the subjects.
We divided the patients according to their aneurysmal site, in 
terms of anterior circulation and posterior circulation. There 
were 83 anterior circulation aneurysm patients and 41 poste-
rior circulation aneurysm patients. The mean prolactin levels 
were 29.98±23.43 and 16.31±15.42 in anterior and posterior 
circulation aneurysms, respectively. We found significant differ-
ences between aneurysmal site and prolactin levels (p=0.001). 
There were no differences in aneurysm site between aneurysm 
neck diameter, dome length/neck size ratio, and Fischer and 
WFNS grades. Radiologic vasospasm detected in diagnostically 
 N %
0 Non anevrizma 10 7.1
1 Right ICA 9 6.4
2 Right MCA 16 11.3
3 Left ANT Com 41 29.1
4 Left ICA 13 9.2
5 Left MCA 14 9.9
6 Right ANT Com 10 7.1
7 Post cerebral 2 1.4
8 Post Com 10 7.1
9 Ant cerebral 3 2.1
10 Basiler 9 6.4
11 PICA 3 2.1
12 Left SCA 1 0.7
Total 141 100.0
Table 1. Aneurysm localization of patients.
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constructed cerebral angiographies was observed in Fischer 
grade and WFNS grades with high prolactin levels. There was 
a statistically significant positive correlation between pro-
lactin and cortisol (p<0.05) (Table 2). There was a statistical-
ly significant positive correlation between prolactin, cortisol, 
and Fischer grade, D/N ratio, and size (mm) (p<0.05). Fischer 
grade, D/N, and cortisol increased as size increased (Table 3).
Discussion
The pathophysiology of neuroendocrine dysfunction upon SAH 
is obscure. It has been suggested that the genesis of these 
adjustments may be the ischemic or hemorrhagic lesions in 
the hypothalamus or pituitary gland. Increased intracrani-
al pressure, local tissue pressure changes upon hemorrhage, 
vasospasm-based ischemia, microinfarctions of the pituitary 
gland, venous stasis, and surgical procedures may damage 
the pituitary gland [3]. The pathogenesis of aSAH [10,15–18] 
can also include traumatic brain injuries, genetic predisposi-
tion, and autoimmunity and neuroinflammatory responses. 
Insufficiencies in all pituitary hormones following SAH have 
been reported to differ from none to 68% in previous stud-
ies [5,11,17,19]. Our results revealed increased prolactin lev-
els beginning 12 h after SAH.
The increase in cortisol during stress is a necessary mecha-
nism for the defense of the human body in the perpetuation 
of its homeostasis. Alterations of the excitability of the neu-
ronal membranes [20] can be immediately activated by glu-
cocorticoids. Cerebrovascular permeability and the choroidal 
transport of water and electrolytes may also be affected, and 
they are crucial for the regulation of liquor synthesis and vol-
ume homeostasis in the brain [19]. Complicated intercom-
munication between the immune system and the hypothala-
mus-pituitary-adrenal axis can also be of crucial physiological 
significance in the stress response [20]. Glucocorticoids pro-
duce a multistep restriction of the immune system that pro-
tects against the aftereffects of extreme inflammatory reac-
tions [20,21]. Our study also revealed that higher levels of 
cortisol were correlated with higher Fisher grades.
It has been shown that prolactin IV infusion mainly causes a 
decline in blood flow and elevates vascular protection in the 
coronary, mesenteric, renal, and iliac vascular beds. The struc-
tures of these reactions have been proven to include beta 2-ad-
renergic receptor-mediated reactions that are connected with 
the intracellular NO pathway [13].
The decline in the tracked blood flow against prolactin IV infu-
sion might be related to a main reaction of the hormone and 
not to concomitant alterations in hemodynamic variables. The 
heart rate and arterial blood pressure of the patients were kept 
consistent, and there were no important alterations in heart fill-
ing pressures and left ventricular dP/dtmax. This case prohib-
ited any secondary intervention from reflexes, local metabolic, 
or natural effects on the reaction of tracked blood flows to pro-
lactin immersion. Moreover, IV immersion of the vehicle only 
at the identical rate with prolactin did not result in the same 
reactions of the immersed hormone. Also, the candid connec-
tion between the hormone and its coronary, mesenteric, renal, 
and iliac reactions was validated in the dose-response study, 
which proved that the increase in regional blood flow could be 
developed by enhancing the dosage amount of the immersed 
hormone. Several lines of evidence suggest that prolactin is 
secreted peripherally by lymphohematopoietic cells [12]. The 
role of prolactin in lymphoproliferation and its effects on cy-
tokine production are also important. Prolactin acts through 
potentiation of T and B cell function [22].
Henderson et al. showed that the coronary, mesenteric, renal, 
and iliac vasoconstriction caused by prolactin immersion con-
tained both the endothelial discharge of NO and its intracellu-
lar direction. Although we did not measure the real discharge 
of NO, the regional vasoconstriction drawn out by hormone 
infusion was counteracted by the local intra-arterial adminis-
tration of L-NAME, which has been proven to prevent the for-
mation of NO [21].
Cortisol
r P n
Prolactine .784** .000* 141
Table 2. Prolactine and cortisol level.
* p<0.05. There were statistically significant positive relationship 
between prolactin and cortisol (p<0.05). As prolactin increases, 
cortisol increases.
Prolactine
r P n
Fischer grade .502** .000* 141
Age .106 .210 141
D/N .189* .025* 141
Size (mm) .126 .135 141
Table 3.  Relationship between prolactine levels and other 
variables.
* p<0.05. The correlation between prolactin levels, Fisher grade 
and D/N ratio were statistically significant (p<0.05). As Fisher 
grade increased, prolactin levels also rised. There was no 
statistically significant relationship between age and size of the 
aneursym (p>0.05).
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In our analysis, patients who presented a more severe clinical 
status on upon WFNS evaluations and greater bleeding on CT 
(Fisher grade) exhibited a higher propensity for endocrinolog-
ical disorders. Klose et al. [23] observed a correlation between 
lower GCS and the presence of hydrocephalus with hormonal 
changes in the first days after SAH.
In patients with SAH, delayed cerebral ischemia with arterial va-
sospasm can be an important cause of disability and death. In 
our treatment protocol, we used the previous version of these 
guidelines, which focused on prevention with oral nimodip-
ine and maintenance of euvolemia, as well as treatment with 
triple-H and endovascular therapy with selective intra-arteri-
al vasodilators and/or balloon angioplasty [24]. We also treat-
ed the patients with acute hydrocephalus by external ventric-
ular drainage (EVD) and/or lumbar drainage.
Mangieri et al. [21] studied the hormonal profiles of patients 
in the hyperacute phase of SAH (the first 24 h). These au-
thors observed an increase in cortisol in all patients studied 
(n=35), a finding that was most likely due to the physiologi-
cal response to stress. Mangieri et al. also observed a higher 
incidence of high prolactin (14.2%). In terms of thyroid hor-
mones, these authors observed high levels of TSH in 14.2% 
of patients, low levels T3 in 14.2% of patients, and low levels 
of T4 in 5.6% of patients; FSH and LH were unaffected [21]. In 
our study, we found high prolactin and cortisol levels in early-
stage SAH. Nakagava et al. [25] described the clinical features 
of cerebral blood flow (CBF) data obtained from single-photon 
emission computed tomography (SPECT) during the risk peri-
od for DCI after SAH. We performed cerebral angioplasty and/
or selective intra-arterial vasodilator therapy in the region of 
hypoperfusion of arterial territories after SPECT in the patients 
with high GCS and neurological regression.
Conclusions
Early detection of vasospasm may prevent morbidity and mor-
tality after aneurysm rupture, and it improve outcomes. On 
the contrary, better selection of patients prevents complica-
tions of aggressive treatment such as induced hypertension 
and hypervolemia, as well as interventional therapies. Elevated 
prolactin levels have a potentially valuable role in identifying 
SAH patients at higher risk of developing vasospasm beyond 
Fischer and WFNS scales. Future studies of related mechanism 
of prolactin secretion in SAH patients may also identify new 
targets of treatment.
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